Type I leucocyte adhesion deficiency in Yemenian family managed with appropriate treatment: A case series

被引:7
|
作者
Cantisani, Carmen [1 ]
Naqeshbandi, Ahmad Faiq [1 ]
Goldust, Mohamad [2 ]
Lampitelli, Salvatore [1 ]
Cantoresi, Franca [1 ]
Alsorori, Ezeldeen [3 ]
机构
[1] Umberto I Hosp, Sapienza Med Sch Rome, UOC Dermatol, Rome, Italy
[2] Mazandaran Univ Med Sci, Dept Dermatol, Sari, Iran
[3] Univ Sci & Technol Hosp, Dept Dermatol, Sanaa, Yemen
关键词
adhesion defects; bacterial infections; primary immunodeficiencies;
D O I
10.1111/dth.12864
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Primary immunodeficiencies are rare, inherited diseases, characterized by altered function or absence of immune cells. Among them is leukocyte adhesion deficiency Type I (LAD-I), an autosomal recessive disorder characterized by primary immunodeficiency, caused by mutations in the ITGB2 gene which produces inability of leucocytes to migrate toward the area of inflammation and is associated with recurrent life-threatening bacterial and fungal infections. Pyoderma gangrenosum (PG) is an uncommon noninfectious neutrophilic dermatosis, characterized by recurrent, necrotic ulcers. It is a diagnosis of exclusion and can be challenging and its management is empirical, with local (topical tacrolimus or intralesional triamcinolone) or systemic immunosuppressive therapy (oral or intravenous glucocorticoids, sulfasalazine, especially in cases associated with Crohn's disease, cyclosporine and, recently, anti-tumor necrosis factor drugs such as Infliximab, Etanercept, and Adalimumab). Though skin ulcerations are common, predominant clinical presentation as PG can often mimic other diseases. It is unusual in children even more in LAD-I. Here, we present a Yemenian family with LAD-I from consanguineous relatives. All patients had history of chronic recurrent skin ulcerations without any bleeding tendency, associated with persistent neutrophilia and requiring steroids and antibiotics. There was no history of delayed cord separation and the condition was initially diagnosed as epidermolysis bullosa, but successively as PG. LAD-I should be kept in mind while evaluating patients with PG especially in children with persistent neutrophilia in the absence of other rheumatological disorders. Its diagnosis is extremely important from the management perspective, as treating these patients without adequate antibiotic cover may be fatal, as happened to one of our patient, and these patients often require hematopoietic stem cell transplantation for permanent cure. Therefore, genetic counseling especially in population with high consanguinity is mandatory.
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Efficient and cost effective transduction of hematopoietic stem cells with lentiviral vectors for the treatment of leukocyte adhesion deficiency type I
    Mesa-Nunez, C.
    Damian, C.
    Fernandez-Garcia, M.
    Diez-Cabezas, B.
    Bueren, J. A.
    Almarza, E.
    HUMAN GENE THERAPY, 2018, 29 (12) : A39 - A40
  • [32] Bone Marrow Transplantation for Leukocyte Adhesion Deficiency-I: Case Report
    Al-Wahadneh, Adel Mohammed
    Haddadin, Issam
    Hamouri, Mufeed
    Omari, Khalifah
    Aejellat, Faten
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2006, 17 (04) : 564 - 567
  • [33] Treatment outcomes of cochlear implantation in pediatric patients with Cockayne syndrome type I: a case series
    Kostova, Mariana
    Banerjee, Anirvan
    JOURNAL OF SURGICAL CASE REPORTS, 2024, 2024 (05):
  • [34] A rare case of leukocyte adhesion deficiency Type 1 with glucose-6-phosphate dehydrogenase deficiency
    Zhang, Y.
    Li, L.
    He, X. -L.
    Liu, H. -F.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1242 - 1242
  • [35] Leukocyte adhesion deficiency type II and fucose therapy: a new case.
    Ma, SH
    Hidalgo, A
    Simonte, S
    Frenette, P
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S37 - S38
  • [36] Hematopoietic stem cell transplantation for the treatment of leukocyte adhesion deficiency type III
    Saultier, Paul
    Alessi, Marie-Christine
    Michel, Gerard
    Chambost, Herve
    PEDIATRICS AND NEONATOLOGY, 2017, 58 (06): : 560 - 561
  • [37] Ex vivo Gene Therapy in a Mouse Model of Leukocyte Adhesion Deficiency Type I
    Almarza, E.
    Leon-Rico, D.
    Aldea, M.
    Sanchez, R.
    Thrasher, A. J.
    Bueren, J. A.
    HUMAN GENE THERAPY, 2014, 25 (11) : A40 - A41
  • [38] Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III
    Bakhtiar, Shahrzad
    Salzmann-Manrique, Emilia
    Blok, Henric-Jan
    Eikema, Dirk-Jan
    Hazelaar, Sheree
    Ayas, Mouhab
    Toren, Amos
    Goldstein, Gal
    Moshous, Despina
    Locatelli, Franco
    Merli, Pietro
    Michel, Gerard
    Ozturk, Gulyuz
    Schulz, Ansgar
    Heilmann, Carsten
    Ifversen, Marianne
    Wynn, Rob F.
    Aleinikova, Olga
    Bertrand, Yves
    Tbakhi, Abdelghani
    Veys, Paul
    Karakukcu, Musa
    Kupesiz, Alphan
    Ghavamzadeh, Ardeshir
    Handgretinger, Rupert
    Unal, Emel
    Perez-Martinez, Antonio
    Gokce, Muge
    Porta, Fulvio
    Aksu, Tekin
    Karasu, Gulsun
    Badell, Isabel
    Ljungman, Per
    Skorobogatova, Elena
    Yesilipek, Akif
    Zuckerman, Tsila
    Bredius, Robbert R. G.
    Stepensky, Polina
    Shadur, Bella
    Slatter, Mary
    Gennery, Andrew R.
    Albert, Michael H.
    Bader, Peter
    Lankester, Arjan
    BLOOD ADVANCES, 2021, 5 (01) : 262 - 273
  • [39] Successful umbilical cord blood transplantation in children with leukocyte adhesion deficiency type I
    Qian, Xiaowen
    Wang, Ping
    Wang, Hongsheng
    Jiang, Wenjin
    Sun, Jinqiao
    Wang, Xiaochuan
    Zhai, Xiaowen
    TRANSLATIONAL PEDIATRICS, 2020, 9 (01) : 34 - 42
  • [40] RESULTS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH LEUKOCYTE ADHESION DEFICIENCY TYPE I
    Hamidieh, A. A.
    Pourpak, Z.
    Alimoghaddam, K.
    Ardalan, M.
    Baboush, G.
    Jalili, M.
    Movahedi, M.
    Moin, M.
    Ghavamzadeh, A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 79 - 79